Lv M - Search Results

1

Generation of a recombinant West Nile virus stably expressing the Gaussia luciferase for neutralization assay.

Zhang PT, Shan C, Li XD, Liu SQ, Deng CL, Ye HQ, Shang BD, Shi PY, Lv M, Shen BF, Qin CF, Zhang B. Zhang PT, et al. Among authors: lv m. Virus Res. 2016 Jan 4;211:17-24. doi: 10.1016/j.virusres.2015.09.015. Epub 2015 Sep 28. Virus Res. 2016. PMID: 26415755

2

A novel human scFv fragment against TNF-alpha from de novo design method.

Chang H, Qin W, Li Y, Zhang J, Lin Z, Lv M, Sun Y, Feng J, Shen B. Chang H, et al. Among authors: lv m. Mol Immunol. 2007 Jul;44(15):3789-96. doi: 10.1016/j.molimm.2007.03.020. Epub 2007 May 7. Mol Immunol. 2007. PMID: 17485112

3

Selective unresponsiveness to the inhibition of p38 MAPK activation by cAMP helps L929 fibroblastoma cells escape TNF-alpha-induced cell death.

Wang J, Tang R, Lv M, Zhang J, Shen B. Wang J, et al. Among authors: lv m. Mol Cancer. 2010 Jan 13;9:6. doi: 10.1186/1476-4598-9-6. Mol Cancer. 2010. PMID: 20070884 Free PMC article.

4

Arg9 facilitates the translocation and downstream signal inhibition of an anti-HER2 single chain antibody.

Hu Y, Qiao C, Lv M, Feng J, Yu M, Shen B, Zhang Q, Li Y. Hu Y, et al. Among authors: lv m. BMC Res Notes. 2012 Jul 2;5:336. doi: 10.1186/1756-0500-5-336. BMC Res Notes. 2012. PMID: 22748113 Free PMC article.

5

Novel anti-CD20 antibody TGLA with enhanced antibody-dependent cell-mediated cytotoxicity mediates potent anti-lymphoma activity.

Lv M, Lin Z, Qiao C, Gen S, Lang X, Li Y, Feng J, Shen B. Lv M, et al. Cancer Lett. 2010 Aug 1;294(1):66-73. doi: 10.1016/j.canlet.2010.01.023. Epub 2010 Mar 3. Cancer Lett. 2010. PMID: 20202740

6

The novel non-mitogenic anti-CD3 antibody, mini-yCD3, delivers a partial TCR signal.

Lv M, Qiao C, Lin Z, Yu M, Hou C, Sun Y, Li Y, Feng J, Shen B. Lv M, et al. Int Immunopharmacol. 2010 Feb;10(2):200-6. doi: 10.1016/j.intimp.2009.10.016. Epub 2009 Nov 12. Int Immunopharmacol. 2010. PMID: 19913640

7

Structured to reduce the mitogenicity of anti-CD3 antibody based on computer-guided molecular design.

Lv M, Li Y, Yu M, Sun Y, Lin Z, Qiao C, Luo Q, Gu X, Huang Y, Feng J, Shen B. Lv M, et al. Int J Biochem Cell Biol. 2007;39(6):1142-55. doi: 10.1016/j.biocel.2007.02.015. Epub 2007 Feb 28. Int J Biochem Cell Biol. 2007. PMID: 17446118

8

Structure-based affinity maturation of a chimeric anti-ricin antibody C4C13.

Luo L, Luo Q, Guo L, Lv M, Lin Z, Geng J, Li X, Li Y, Shen B, Qiao C, Feng J. Luo L, et al. Among authors: lv m. J Biomol Struct Dyn. 2014;32(3):416-23. doi: 10.1080/07391102.2013.771380. Epub 2013 Mar 25. J Biomol Struct Dyn. 2014. PMID: 23527922

9

A novel anti-TNF scFv constructed with human antibody frameworks and antagonistic peptides.

Geng S, Chang H, Qin W, Lv M, Li Y, Feng J, Shen B. Geng S, et al. Among authors: lv m. Immunol Res. 2015 Jul;62(3):377-85. doi: 10.1007/s12026-015-8667-8. Immunol Res. 2015. PMID: 26059602

10

Suitable transmembrane domain significantly increase the surface-expression level of Fc(epsilon)RIalpha in 293T cells.

Qiao C, Guo L, Sun J, Li Y, Lin Z, Lv M, Feng J, Shen B. Qiao C, et al. Among authors: lv m. J Biotechnol. 2009 Feb 5;139(3):195-202. doi: 10.1016/j.jbiotec.2008.11.007. Epub 2008 Dec 6. J Biotechnol. 2009. PMID: 19110016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,867 results

Search Page

Filters